United States · Series C startup

Who invested in Boundless Bio

2 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$146Mraised across 2 rounds since 2019, from 2 sources

$46MSeries A$100MSeries C
Latest round
Series C, $100MMay 2023
Step-upi
2.2×
Investors
11 (2 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020202120222023
$46MSeries A$100MSeries C
First round
Series A, $46M
Sept 2019
Biggest round
$100M
Series C · May 2023
Between rounds
3.6 years
from the last two

The rounds

  1. May 2023
    Series C$100M5 new1 returning

    Source recordedSEC filing: $100M sold, first sale Apr 2023

  2. Sept 2019

Founders and team

From Boundless Bio's own website and the SEC filings it signed: 6 on the team.

  • Angela PietrofesoVice President, Clinical Operations
  • David HinkleSenior Vice President, Finance & Controller
  • Jessica OienChief Legal Officer
  • Meredith WesleyChief Human Resources Officer
  • Jennifer D. LewDirector
  • Zachary D. HornbyDirector, Executive Officeri

On the board, as filediBenjamin D. CravattChristine D. BrennanFabio D. PucciJakob D. LovenJonathan D. LimKristina D. Burow

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

ARCH Venture PartnersVC firm2rounds, led 1
City Hill VenturesVC firm1round, led 1
RA Capital ManagementPrivate equity1round
FidelityVC firm1round
Vertex VenturesVC firm1round
Redmile GroupVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Boundless Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Nextech InvestPrivate equityPer its own site

Quick answers about Boundless Bio

Who invested in Boundless Bio?

Boundless Bio's investors include ARCH Venture Partners, City Hill Ventures, RA Capital Management, Fidelity and Wellington Management, and 6 more on record.

How much has Boundless Bio raised?

Boundless Bio has raised $146M across 2 rounds since 2019.

When did Boundless Bio last raise?

Boundless Bio's most recent round was a Series C of $100M in May 2023.

What was Boundless Bio's biggest round?

Its most recent round, $100M in May 2023, is also its largest on record.

Who backed Boundless Bio first?

Boundless Bio's first round on record, in Sept 2019, was backed by ARCH Venture Partners, City Hill Ventures and Vertex Ventures China and 3 others.

What stage is Boundless Bio at?

Boundless Bio's latest named round is a Series C, in May 2023.

Where is Boundless Bio based?

Boundless Bio is based in the United States.

Who led Boundless Bio's rounds?

ARCH Venture Partners led the Series A in 2019.

Companies like Boundless Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.